News
NEWS

  • news

Joint research with the Institute of Medical Science, the University of Tokyo started.

Celaid Therapeutics has concluded a joint research agreement with the Institute of Medical Science, the University of Tokyo (Division of Stem Cell Biology, specially appointed associate professor Satoshi Yamazaki) on the development of basic technology, and its applied research, aimed at the clinical application of HSCs.

Through this joint research, we will be working to promote development aimed at clinical application.

Copyright© セレイド セラピューティクス / Celaid Therapeutics , 2021 All Rights Reserved Powered by STINGER.